Do physiological roles foster persistance of drug/multidrug-efflux transporters? A case study

Nature Reviews Microbiology

Volumn 3, Issue 7, 2005, Pages 566-572

  Krulwich, Terry A ^a   Lewinson, Oded ^b   Padan, Etana ^c   Bibi, Eitan ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIBIOTIC AGENT; ANTIPORTER; CARRIER PROTEIN; CHLORAMPHENICOL; DAUNORUBICIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; TETRAPHENYLPHOSPHONIUM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERIAL MEMBRANE; BINDING SITE; CELL PH; CHEMICAL MODIFICATION; ESCHERICHIA COLI; GENE OVEREXPRESSION; GENETIC CODE; HOMEOSTASIS; ION EXCHANGE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; YERSINIA ENTEROCOLITICA;

ANTI-BACTERIAL AGENTS; ANTIPORTERS; BACTERIA; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI PROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; POTASSIUM-HYDROGEN ANTIPORTERS; SODIUM-HYDROGEN ANTIPORTER; TETRACYCLINE; TETRACYCLINE RESISTANCE;

BACILLUS SUBTILIS; ESCHERICHIA COLI; YERSINIA ENTEROCOLITICA;

EID: 21344436181     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1181     Document Type: Article

References (81)

1. Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Med. 10, S122-S129 (2004).
2. Walsh, C. Antibiotics: Actions, Origins, Resistance (ASM Press, Washington, DC, 2003).
3. Livermore, D. M. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36, S11-S23 (2003).
4. Projan, S. J. & Shlaes, D. M. Antibacterial drug discovery: is it all downhill from here? Clin. Microbiol. Infect. 10, 18-22 (2004).
5. Gillespie, S. H. Antibiotic resistance in the absence of selective pressure. Int. J. Antimicrob. Agents 17, 171-176 (2001).
6. Aharoni, A. et al. The "evolvability" of promiscuous protein functions. Nature Genet. 37, 73-76 (2005).
7. Saier, M. H. Jr et al. Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12, 265-274 (1998).
8. Barbosa, T. M. & Levy, S. B. The impact of antibiotic use on resistance development and persistence. Drug Resist. Updat. 3, 303-311 (2000).
9. Lessard, I. A. & Walsh, C. T. VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function? Proc. Natl Acad. Sci. USA 96, 11028-11032 (1999).
10. Neyfakh, A. A. Natural functions of bacterial multidrug transporters. Trends Microbiol. 5, 309-313 (1997)
11. Markham, P. N. & Neyfakh, A. A. Efflux-mediated drug resistance in Gram-positive bacteria. Curr. Opin. Microbiol. 4, 509-514 (2001).
12. Cheng, J., Guffanti, A. A., Wang, W., Krulwich, T. A. & Bechhofer, D. H. Chromosomal tetA(L) gene of Bacillus subtilis: regulation of expression and physiology of a tetA(L) deletion strain. J. Bacteriol. 178, 2853-2860 (1996).
13. Lewinson, O., Padan, E. & Bibi, E. Alkalitolerance: a biological function for a multidrug transporter in pH homeostasis. Proc. Natl Acad. Sci. USA 101, 14073-14078 (2004).
14. Amano, H., Ives, C. L., Bott, K. F. & Shishido, K. A limited number of Bacillus subtilis strains carry a tetracycline-resistance determinant at a site close to the origin of replication. Biochim. Biophys. Acta 1088, 251-258 (1991).
15. Edgar, R. & Bibi, E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteriol. 179, 2274-2280 (1997).
16. Li, X. Z. & Nkaido, H. Efflux-mediated drug resistance in bacteria. Drugs 64, 159-204 (2004).
17. McMurry, L. M. & Levy, S. B. in Gram-Positive Pathogens (eds Fischetti, V. A., Novick, R. P., Ferretti, J. J., Portnoy, D. A. & Rood, J. I.) 660-677 (ASM Press, Washington DC, 2000).
18. Saier, M. H. Jr & Paulsen, I. T. Phylogeny of multidrug transporters. Semin. Cell. Dev. Biol. 12, 205-213 (2001).
19. Paulsen, I. T. Multidrug efflux pumps and resistance: regulation and evolution. Curr. Opin. Microbiol. 6, 446-451 (2003).
20. Mitchell, P. Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature 191, 144-148 (1961).
21. West, I. C. & Mitchell, P. Proton/sodium ion antiport in Escherichia coli. Biochem. J. 144, 87-90 (1974).
22. Li, X. Z., Ma, D., Livermore, D. M. & Nikaido, H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to β-lactam resistance. Antimicrob. Agents Chemother. 38, 1742-1752 (1994).
23. Webber, M. A. & Piddock, L. J. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother 51, 9-11 (2003).
24. Edgar, R. & Bibi, E. A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. EMBO J. 18, 822-832 (1999).
25. Ives, C. L. & Bott, K. F. Cloned Bacillus subtilis chromosomal DNA mediates tetracycline resistance when present in multiple copies. J. Bacteriol. 171, 1801-1810 (1989).
26. + antiporter that is physiologically important at elevated pH. J. Biol. Chem. 269, 27365-27371 (1994).
27. Lewinson, O. et al. The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions. Proc. Natl Acad. Sci. USA 100, 1667-1672 (2003).
28. Padan, E., Zilberstein, D. & Schuldiner, S. pH homeostasis in bacteria. Biochim. Biophys. Acta 650, 151-166 (1981).
29. Booth, I. R. Regulation of cytoplasmic pH in bacteria. Microbiol. Rev. 49, 359-378 (1985).
30. Speelmans, G., Poolman, B., Abee, T. & Konings, W. N. Energy transduction in the thermophilic anaerobic bacterium Clostridium fervidus is exclusively coupled to sodium ions. Proc. Natl Acad. Sci. USA 90, 7975-7979 (1993).
31. +-resistance and pH homeostasis in Bacillus: an alkaliphile versus a neutralophile. J. Exp. Biol. 196, 457-470 (1994).
32. MacNab, R. M. & Castle, A. M. A variable stoichiometry model for pH homeostasis in bacteria. Biophys. J. 52, 637-647 (1987).
33. + antiporters. Biochim. Biophys. Acta 1505, 144-157 (2001).
34. + exchanger isoforms. Am. J. Physiol. 268, C283-C296 (1995).
35. + exchangers of mammalian cells. J. Biol. Chem. 272, 22373-22376 (1997).
36. + exchanger NHE1 revealed by symmetrical intermolecular cross-linking and selective co-immunoprecipitation. Biochemistry 43, 11135-11143 (2004).
37. Plack, R. H. Jr & Rosen, B. P. Cation/proton antiport systems in Escherichia coli. Absence of potassium/proton antiporter activity in a pH-sensitive mutant. J. Biol. Chem. 255, 3824-3825 (1980).
38. + in pH homeostasis and growth of the marine bacterium Vibrio alginolyticus. J. Gen. Microbiol. 138, 1271-1276 (1992).
39. + antiport catalyzed by the Bacillus subtilis TetA(L) transporter expressed in Escherichia coli. J. Bacteriol. 177, 4557-4561 (1995).
40. + exchange. Proc. Natl Acad. Sci. USA 93, 14446-14451 (1996).
41. Evans, D. F. et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29, 1035-1041 (1988).
42. Lemke, T., Stingl, J., Egert, M., Friedrich, M. W. & Brune, A. Physicochemical conditions and microbial activities in the highly alkaline gut of the humus-feeding larva of Pachnoda ephippiata (Coleoptera: Scarabaeidae). Appl. Environ. Microbiol. 69, 6650-6658 (2003).
43. Krulwich, T. A., Guffanti, A. A. & Ito, M. in Mechanisms by which Bacterial Cells Respond to pH 167-182 (Novartis Found. Symp. 221, Wiley, Chichester, 1999).
44. Padan, E. & Schuldiner, S. in The Handbook of Biological Physics, Vol. II. Transport Processes in Membranes (eds Konings, W. N., Kaback, H. R. & Lolkema, J.) 501-531 (Elsevier Science, Amsterdam, 1996).
45. Padan, F. & Krulwich, T. A. in Bacterial Stress Response (eds Storz, G. & Hengge-Aronis, R.) 117-130 (ASM Press, Washington, DC, 2000).
46. + uptake. J. Biol. Chem. 273, 26447-26454 (1998).
47. Epstein, W. The roles and regulation of potassium in bacteria. Prog. Nucleic Acid Res. Mol. Biol. 75, 293-320 (2003).
48. + antiporters: characterization of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences. J. Bacteriol. 184, 4722-4732 (2002).
49. Lewinson, O. & Bibi, E. Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA. Biochemistry 40, 12612-12618 (2001)
50. +antiporter. Biochim. Biophys. Acta 1658, 2-13 (2004).
51. Sheridan, R. P. & Chopra, I. Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis. Mol. Microbiol. 5, 895-900 (1991).
52. Hall, B. Predicting the evolution of antibiotic resistance genes. Nature Rev. Microbiol. 2, 430-435 (2004).
53. Neyfakh, A. A. Mystery of multidrug transporters: the answer can be simple. Mol. Microbiol. 44, 1123-1130 (2002).
54. Zheleznova, E. E. et al. A structure-based mechanism for drug binding by multidrug transporters. Trends Biochem. Sci. 25, 39-43 (2000).
55. Griffith, J. K. et al. Membrane transport proteins: implications of sequence comparisons. Curr. Opin. Cell Biol. 4, 684-695 (1992).
56. Jin, J., Guffanti, A. A., Beck, C. & Krulwich, T. A. Twelve-transmembrane-segment (TMS) version (ΔTMS VII-VIII) of the 14-TMS Tet(L) antibiotic resistance protein retains monovalent cation transport modes but lacks tetracycline efflux capacity. J. Bacteriol. 183, 2667-2671 (2001).
57. +, alkali, and tetracycline resistance. J. Bacteriol. 182, 2088-2095 (2000).
58. Stasinopoulos, S. J., Farr, G. A. & Bechhofer, D. H. Bacillus subtilis tetA(L) gene expression: evidence for regulation by translational reinitiation. Mol. Microbiol. 30, 923-932 (1998).
59. Adler, J. & Bibi, E. Determinants of substrate recognition by the Escherichia coli multidrug transporter MdfA identified on both sides of the membrane. J. Biol. Chem. 279, 8957-8965 (2004).
60. Levin, B. R., Perrot, V. & Walker, N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154, 985-997 (2000).
61. Lenski, R. E., Simpson, S. C. & Nguyen, T. T. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J. Bacteriol. 176, 3140-3147 (1994).
62. Andersson, D. I. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6, 452-456 (2003).
63. Maisnier-Patin, S. & Andersson, D. I. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 155, 360-369 (2004).
64. Schiemann, D. A. Alkalotolerance of Yersinia enterocolitica as a basis for selective isolation from food enrichments. Appl. Environ. Microbiol. 46, 22-27 (1983).
65. Ives, C. L. & Bott, K. F. Characterization of chromosomal DNA amplifications with associated tetracycline resistance in Bacillus subtilis. J. Bacteriol. 172, 4936-4944 (1990).
66. Bechhofer, D. H. & Stasinopoulos, S. J. tetA(L) mutants of a tetracycline-sensitive strain of Bacillus subtilis with the polynucleotide phosphorylase gene deleted. J. Bacteriol. 180, 3470-3473 (1998).
67. Chopra, I. & Roberts, M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232-260 (2001).
68. Guillaume, G., Ledent, V., Moens, W. & Collard, J. M. Phylogeny of efflux-mediated tetracycline resistance genes and related proteins revisited. Microb. Drug Resist. 10, 11-26 (2004).
69. Chopra, I. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors. Drug Resist. Updat. 5, 119-125 (2002).
70. Lomovskaya, O. & Watkins, W. J. Efflux pumps: their role in antibacterial drug discovery. Curr. Med. Chem. 8, 1699-1711 (2001).
71. Busch, W. & Saier, M. H. Jr. The transporter classification (TC) system, 2002. Crit. Rev. Biochem. Mol. Biol. 37, 287-337 (2002).
72. Abramson, J., Iwata, S. & Kaback, H. R. Lactose permease as a paradigm for membrane transport proteins. Mol. Membr. Biol. 21, 227-236 (2004).
73. + antiporter TetA(K) from Staphylococcus aureus. J. Bacteriol. 179, 3786-3789 (1997).
74. + antiporter. FEBS Lett. 365, 193-197 (1995).
75. Jin, J. & Krulwich, T. A. Site-directed mutagenesis studies of selected motif and charged residues and of cysteines of the multifunctional tetracycline efflux protein Tet(L). J. Bacteriol. 184, 1796-1800 (2002).
76. Rosen, B. P. Ion extrusion systems in E. coli. Methods Enzymol. 125, 328-386 (1986).
77. Venturi, M. & Padan, E. in A Practical Guide to Membrane Protein Purification (eds Hunts, C., Von Jagow, G. & Schagger, H.) 179-190 (Academic Press/Elsevier Science, San Diego, California, 2003).
78. Viitanen, P., Newman, M. J., Foster, D. L., Wilson, T. K. & Kaback, H. R. Purification, reconstitution, and characterization of the lac permease of Escherichia coli. Methods Enzymol. 125, 429-452 (1986).
79. Aires, J. R. & Nikaido, H. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187, 1923-1929 (2005).
80. Ito, M. et al. MotPS is the stator-force generator for motility of alkaliphilic Bacillus and its homologue is a second funtional Mot in Bacillus subtilis. Mol. Microbiol. 53, 1035-1049 (2004).
81. +-lactate antiporter that enhances growth on malate at low protonmotive force. J. Biol. Chem. 275, 30287-30292 (2000).